Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 122497
Published online Oct 15, 2026. doi: 10.4251/wjgo.122497
Published online Oct 15, 2026. doi: 10.4251/wjgo.122497
Table 6 Comparison of first-line chemotherapy efficacy between the two groups in subgroups with different driver gene statuses, n (%)
| Group | n | RAS-mutantion | n | BRAF V600E mutation | n | Wild-type | |||
| ORR | DCR | ORR | DCR | ORR | DCR | ||||
| Normal flora group | 22 | 12 (54.55) | 19 (86.36) | 3 | 1 (33.33) | 2 (66.67) | 23 | 15 (65.22) | 21 (91.30) |
| Abnormal flora group | 24 | 10 (29.41) | 21 (61.76) | 7 | 0 (0.00) | 2 (28.57) | 35 | 12 (34.29) | 24 (68.57) |
| χ2 value | - | 3.538 | 3.960 | - | - | - | - | 5.337 | 4.125 |
| P value | - | 0.060 | 0.047 | - | 0.300 | 0.500 | - | 0.021 | 0.042 |
- Citation: Wang Y, Dong YW, Wang Y, Jin YY, Zhou YX, Li Y. Association between gut microbial dysbiosis and clinical prognosis of advanced colorectal cancer. World J Gastrointest Oncol 2026; 18(10): 122497
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/122497.htm
- DOI: https://dx.doi.org/10.4251/wjgo.122497